Publications by authors named "C Farmakidis"

Claim this Profile
S
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study.
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, Richard J Nowak, Constantine Farmakidis

Lancet Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge

Ther Adv Neurol Disord· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-dystrophic myotonia: 2-year clinical and patient reported outcomes.
Timothy R Fullam, Swathy Chandrashekhar, Constantine Farmakidis, Omar Jawdat, Mamatha Pasnoor

Muscle Nerve· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
James F Howard, Richard J Nowak, Gil I Wolfe, Miriam L Freimer, Tuan H Vu, Constantine Farmakidis

JAMA Neurol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part II: New and novel agents.
Constantine Farmakidis, Mazen M Dimachkie, Mamatha Pasnoor, Richard J Barohn

Muscle Nerve· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis